Atrás
Rango del Día
$13.68
$14.11
Rango de 52 Semanas
$4.97
$17.09
Volumen
2,263,417
Promedio 50D / 200D
$14.28
/
$9.99
Cierre Anterior
$13.89
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -12.6 | 0.4 |
| P/B | — | 2.9 |
| ROE % | -313.3 | 3.9 |
| Net Margin % | -8.4 | 3.8 |
| Rev Growth 5Y % | 3.3 | 10.0 |
| D/E | — | 0.2 |
Precio Objetivo de Analistas
Hold
$17.50
+25.4%
Low: $17.00
High: $18.00
EPS Futuro
-$0.23
Ingresos Est.
3 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
$0.05
$0.05 – $0.05
|
3.1 B | 2 |
| FY2026 |
-$0.23
-$0.23 – -$0.23
|
3 B | 2 |
Puntos Clave
Revenue grew 3.29% annually over 5 years — modest growth
Negative free cash flow of -294.52M
ROIC of 0.19% — low return on invested capital
Interest coverage of 0.07× — tight debt servicing
Crecimiento
Revenue Growth (5Y)
3.29%
Revenue (1Y)4.77%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-313.25%
ROIC0.19%
Net Margin-8.41%
Op. Margin0.55%
Seguridad
Debt / Equity
N/A
Current Ratio3.62
Interest Coverage0.07
Valoración
P/E Ratio
-12.63
P/B RatioN/A
EV/EBITDA565.16
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.77% | Revenue Growth (3Y) | 4.39% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 3.29% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3.12B | Net Income (TTM) | -262.69M |
| ROE | -313.25% | ROA | -4.41% |
| Gross Margin | 20.64% | Operating Margin | 0.55% |
| Net Margin | -8.41% | Free Cash Flow (TTM) | -294.52M |
| ROIC | 0.19% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 3.62 |
| Interest Coverage | 0.07 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -12.63 | P/B Ratio | N/A |
| P/S Ratio | 1.06 | PEG Ratio | -0.39 |
| EV/EBITDA | 565.16 | Dividend Yield | 0.00% |
| Market Cap | 3.32B | Enterprise Value | 9.70B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.12B | 2.98B | 2.87B | 2.74B | 2.75B |
| Net Income | -262.69M | -201.94M | -189.01M | -238.43M | -99.29M |
| EPS (Diluted) | -1.11 | -0.89 | -0.84 | -1.25 | -0.54 |
| Gross Profit | 645.02M | 807.43M | 744.71M | 513.94M | 488.58M |
| Operating Income | 17.17M | 46.53M | 18.41M | -42.69M | -216.94M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5.95B | 6.34B | 5.57B | 5.94B | 6.41B |
| Total Liabilities | 6.00B | 6.12B | 5.17B | 5.35B | 5.71B |
| Shareholders' Equity | -44.75M | 212.48M | 403.66M | 582.61M | 697.40M |
| Total Debt | 6.66B | 5.65B | 4.73B | 4.89B | 5.23B |
| Cash & Equivalents | 279.12M | 308.93M | 277.97M | 398.85M | 347.03M |
| Current Assets | 553.94M | 512.94M | 478.37M | 637.09M | 698.99M |
| Current Liabilities | 153.23M | 579.76M | 600.12M | 641.21M | 631.95M |